Deborah Kurrasch‐Orbaugh

Serotonin 5-Hydroxytryptamine2A Receptor-Coupled Phospholipase C and Phospholipase A2 Signaling Pathways Have Different Receptor Reserves

Deborah Kurrasch‐Orbaugh, Val J. Watts, Eric L. Barker et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 165 citations

Life Sciences, Biochemistry, Pharmacology +17

A complex signaling cascade links the serotonin_2A receptor to phospholipase A₂ activation: the involvement of MAP kinases

Deborah Kurrasch‐Orbaugh, Jason C. Parrish, Val J. Watts et al. · Journal of Neurochemistry · 2003 · 133 citations

Life Sciences, Cell Biology, Pharmacology +17

Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines

Joseph B. Blair, Deborah Kurrasch‐Orbaugh, Danuta Marona‐Lewicka et al. · Journal of Medicinal Chemistry · 2000 · 132 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Enantiospecific Synthesis and Pharmacological Evaluation of a Series of Super-Potent, Conformationally Restricted 5-HT_2A/2C Receptor Agonists

James J. Chambers, Deborah Kurrasch‐Orbaugh, Matthew Parker et al. · Journal of Medicinal Chemistry · 2001 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Lysergamides of Isomeric 2,4-Dimethylazetidines Map the Binding Orientation of the Diethylamide Moiety in the Potent Hallucinogenic Agent <i>N</i>,<i>N</i>-Diethyllysergamide (LSD)

David E. Nichols, Stewart Frescas, Danuta Marona‐Lewicka et al. · Journal of Medicinal Chemistry · 2002 · 89 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12